News

MINNEAPOLIS, July 11, 2023 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes and resident care solutions to long-term care facilities, announced today the launch of Assure PT Care PT/INR ...
Research suggests that extending the period between warfarin dose assessments from 4 weeks to 12 weeks is safe for adults receiving long-term, steady doses.
(HealthDay News) — For hospitalized patients, international normalized ratio (INR) monitoring less frequently than daily is associated with increased odds of warfarin-associated adverse events ...
Alere to Initiate Voluntary Withdrawal of the Alere INRatio and INRatio2 PT/INR Monitor System ...
“These findings support rivaroxaban as a viable alternative to warfarin, offering predictable dosing and eliminating the need for routine INR monitoring in patients with post-MI left ventricular ...
Cabozantinib in the elderly with metastatic renal cell carcinoma undergoing geriatric G8 screening test: A prospective multicenter observational study (ZEBRA/MEET-URO 9). Warfarin Competition at ...